Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062572) titled 'A Nationwide Survey on the Prevalence of Oligometastases in Head and Neck Cancer' on Aug. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Gifu University
Condition:
Condition - Head and Neck Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the current clinical practices and treatment outcomes for oligo-metastases in head and neck cancer, to compare and analyze treatment outcomes across different treatment modalities, and to conduct an exploratory evaluation of clinical factors associated with prognosis and factors influencing treatment decisions.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 1
years-old
=
Gender - Male and Female
Key inclusion criteria - This study will collect information via questionnaires from each institution regarding patients who meet the following criteria, and will then analyze that data.
6.1. Inclusion Criteria
1. Head and neck cancer
2. The primary tumor is under control
3. Curative treatment is possible
4. No more than three metastatic lesions confined to a single organ
Patients must meet all of the above criteria (for the purposes of this study, the above criteria constitute the definition of oligometastasis).
Key exclusion criteria - Other than the selection criteria listed above.
Target Size - 2050
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 07 Month 15 Day
Date of IRB - 2026 Year 08 Month 05 Day
Anticipated trial start date - 2026 Year 09 Month 30 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071622
Disclaimer: Curated by HT Syndication.
